Public SEC Form D records
Biotech Series A Form D filings - March 2025
This page lists the 7 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series A stage in March 2025 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 7
- Issuers
- 7
- Combined disclosed
- $50.3M
Directory links
Filing records
7 crawlable filing links in this facet.
- UBIVAC, INC.March 11, 2025 / Reg D 506(b) / OR$4.5M
- GT Metabolic Solutions IncMarch 11, 2025 / Reg D 506(b) / CA$25.4M
- Infinity Bio, Inc.March 11, 2025 / Reg D 506(b) / MD$5.0M
- Tiga Labs, Inc.March 10, 2025 / Reg D 506(b) / VA$2.8M
- NRX Pharmaceuticals, Inc.March 7, 2025 / Reg D 506(b) / DE$3.5M
- Claris Biotherapeutics, Inc.March 7, 2025 / Reg D 506(b) / NJ$3.3M
- Living Ink Technologies, Inc.March 7, 2025 / Reg D 506(b) / CO$5.8M